Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Portola Pharmaceuticals and Merck Announce that Phase 2 Study Showed Investigational Factor Xa Inhibitor, Betrixaban, Reduced Incidence of Bleeding Compared to Warfarin in Patients with Atrial Fibrill
March 15, 2010
from Business Wire News Releases
Dr. Julie Gerberding Named President of Merck Vaccines
December 21, 2009
from Business Wire News Releases
New Merck Begins Operations
November 04, 2009
from Business Wire News Releases
Trading Outlook for Novavax Inc. Issued by InvestorSoup.com
November 04, 2009
from GlobeNewswire News Releases
Merck and Schering-Plough to Complete Merger Today
November 03, 2009
from Business Wire News Releases
Wall Street News Alert: Ahead of the Bell: HearAtLast Holdings - November 3, 2009
November 03, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. Read More
from Marketwired News Releases
Standard & Poor's Announces Changes to U.S. Indices
October 29, 2009
from PR Newswire
Merck and Schering-Plough Receive Approvals From U.S. Federal Trade Commission, Swiss Competition Commission and Canadian Competition Bureau for Merger
October 29, 2009
from Business Wire News Releases
SAFE-BioPharma Receives Safe Harbor Certification
October 27, 2009
from Business Wire News Releases
Merck and Schering-Plough Receive Approval From European Commission for Merger
October 23, 2009
from Business Wire News Releases
Critical Alerts for Schlumberger, Merck, Deere, Delta, and AutoZone Released by Seven Summits Research
October 22, 2009
from PR Newswire
Merck Announces Third-Quarter 2009 Financial Results
October 22, 2009
from Business Wire News Releases
CDC Advisory Committee on Immunization Practices Votes for Permissive Use and for Vaccines for Children Funding for GARDASIL® for Boys and Young Men
October 21, 2009
from Business Wire News Releases
SNAP Diagnostics is First Diagnostics Company to Join SAFE-BioPharma Association
October 21, 2009
from Business Wire News Releases
FDA Approves GARDASIL® for Use in Boys and Young Men
October 16, 2009
from Business Wire News Releases
300 Doctors at your Fingertips: New Merck Manuals Deliver Convenient and Trusted Medical Information to Consumers
October 08, 2009
from Business Wire News Releases
McDougall Scientific is First CRO to Join SAFE-BioPharma Association
October 07, 2009
from Business Wire News Releases
Siperian Congratulates Merck for Being Named a Finalist for the Gartner Master Data Management Excellence Award
October 05, 2009
from PR Newswire
Critical Alerts For Merck, Urban Outfitters, Goldcorp, International Paper and Archer Daniels Midland
September 28, 2009
from PR Newswire
Merck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for AFLURIA®, Seasonal Influenza Vaccine from CSL Biotherapies
September 28, 2009
from Business Wire News Releases
Merck Receives Positive CHMP Opinion for JANUVIA® (sitagliptin) and JANUMET® (sitagliptin/metformin) as Add-On to Insulin in the European Union
September 25, 2009
from Business Wire News Releases
Merck Statement About JANUVIA™ (sitagliptin) and JANUMET™ (sitagliptin/metformin)
September 25, 2009
from Business Wire News Releases
Merck and QIAGEN Collaborate to Accelerate Access to Cervical Cancer Vaccination and Screening in Developing Countries
September 23, 2009
from Business Wire News Releases
Sanofi-aventis Completes Acquisition of Merck's Interest in Merial
September 18, 2009
from Business Wire News Releases
Wellcome Trust and Merck Launch First of Its Kind Joint Venture to Develop Affordable Vaccines for Low-Income Countries
September 17, 2009
from Business Wire News Releases
Merck's ISENTRESS® (raltegravir) Tablets Studied in Comparison to Efavirenz in Combination Therapy Through 96 Weeks in HIV-1 Treatment-Naïve Patients
September 13, 2009
from Business Wire News Releases
Mistrial Declared in First Federal FOSAMAX® Trial
September 11, 2009
from Business Wire News Releases
Merck Updates Status of Clinical Development Programs for Investigational CGRP Receptor Antagonist Treatments for Acute Migraine; MK-3207 Clinical Development Discontinued
September 10, 2009
from Business Wire News Releases
FDA Advisory Committee Recommends Approval for Use of GARDASIL® in Boys and Men
September 09, 2009
from Business Wire News Releases
Merck Acquires Leading Manufacturer of Effect Pigments in China
September 09, 2009
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here